The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

The cases of H3N2 flu have been reported in Delhi and other NCR cities. A recent survey said that nearly 69% of households in Delhi-NCR have reported at least one member down with flu-like illness ...

The approval of Medicare coverage could potentially unlock a large market segment for Lucid Diagnostics' devices. Read why LUCD stock is a Hold.

Research published in the journal BMJ Open in May found that an annual blood test for cancer could lead to 49 per cent fewer ...

This work is the first to introduce a practical framework for addressing one of the biggest obstacles to healthcare AI adoption: clinician trust. It emphasizes transparency and adaptability as ...

An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.

With their innovative contact lens, ERG tests, which are used to diagnose hereditary retinal diseases and evaluate prognosis ...

When the dreaded malfunction indicator light turns on, it’s not the end of the world. Here’s how to cope with an MIL!